As of August 28, 2026, Rigel Pharmaceuticals, Inc. (RIGL) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. Rigel Pharmaceuticals, Inc. has a market capitalization of $564.13M, 18.68M shares outstanding, 13 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RIGL.
Market Data
Market Cap$564.13M
Shares Outstanding18.68M
Float15.94M
Cash$95.33M
Debt$45.00M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 0.6% shares (2026Q1 vs prior)
13 institutional holders · 157.8K shares
#1
Quinn Opportunity Partners LLC
41.4K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
39.5K shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
34.0K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest3.09M
Days to Cover10.6
% of Float19.4%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track RIGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RIGL — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for RIGL
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.